Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
February-2022 Volume 23 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
February-2022 Volume 23 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Galectin‑1 alleviates myocardial ischemia‑reperfusion injury by reducing the inflammation and apoptosis of cardiomyocytes

  • Authors:
    • Dengke Ou
    • Dan Ni
    • Rong Li
    • Xiaobo Jiang
    • Xiaoxiao Chen
    • Hongfei Li
  • View Affiliations / Copyright

    Affiliations: Department of Cardiovascular Medicine, Chengdu Fifth People's Hospital, Chengdu, Sichuan 611130, P.R. China, Department of Nuclear Medicine, Chengdu Fifth People's Hospital, Chengdu, Sichuan 611130, P.R. China, Department of Interventional Therapy, Chengdu Fifth People's Hospital, Chengdu, Sichuan 611130, P.R. China
    Copyright: © Ou et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 143
    |
    Published online on: December 15, 2021
       https://doi.org/10.3892/etm.2021.11066
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Myocardial ischemia‑reperfusion injury (MIRI) is one of the leading causes of morbidity and mortality worldwide, for which there is no effective treatment. The present study aimed to assess novel methods of clinical MIRI treatment by studying the effects of galectin‑1(Gal‑1) on MIRI. Male 2‑month‑old Sprague Dawley rats and the rat cardiomyocyte cell line H9c2 were utilized in the present study. A rat model of MIRI was constructed by ligating the left anterior descending coronary artery, which was subsequently treated with Gal‑1. Differences in myocardial injury were then assessed by hematoxylin and eosin (H&E) staining. In addition, the levels of inflammation and apoptosis in rat myocardial tissue were determined by immunohistochemistry staining. Hypoxia‑reoxygenation was used to construct a model of MIRI in H9c2 cells. The effect of Gal‑1 on the apoptosis and viability of H9c2 cells was also verified by flow cytometry and a Cell Counting Kit‑8 assay. The results of H&E staining revealed that Gal‑1 alleviated MIRI. Echocardiography demonstrated that Gal‑1 improved cardiac function in rats following MIRI. In addition, MIRI increased levels of inflammation and apoptosis in rat myocardial tissues, with Gal‑1 treatment reversing this effect. In cellular experiments, Gal‑1 served anti‑inflammatory and anti‑apoptotic effects in hypoxic/reoxygenated cardiomyocytes. In conclusion, Gal‑1 served a significant protective effect on the myocardial tissue after ischemia‑reperfusion by reducing the level of inflammation and apoptosis in cardiomyocytes.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

View References

1 

Popescu CP, Florescu SA, Hasbun R, Harxhi A, Evendar R, Kahraman H, Neuberger A, Codreanu D, Zaharia MF, Tosun S, et al: Prediction of unfavorable outcomes in West Nile virus neuroinvasive infection-Result of a multinational ID-IRI study. J Clin Virol. 122(104213)2019.PubMed/NCBI View Article : Google Scholar

2 

Henry JJD, Delrosario L, Fang J, Wong SY, Fang Q, Sievers R, Kotha S, Wang A, Farmer D, Janaswamy P, et al: Development of injectable amniotic membrane matrix for postmyocardial infarction tissue repair. Adv Healthc Mater. 9(e1900544)2020.PubMed/NCBI View Article : Google Scholar

3 

Murthy SB, Diaz I, Wu X, Merkler AE, Iadecola C, Safford MM, Sheth KN, Navi BB and Kamel H: Risk of arterial ischemic events after intracerebral hemorrhage. Stroke. 51:137–142. 2020.PubMed/NCBI View Article : Google Scholar

4 

GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: A systematic analysis for the global burden of disease study 2017. Lancet. 392:1789–1858. 2018.PubMed/NCBI View Article : Google Scholar

5 

Jackson CA, Kerssens J, Fleetwood K, Smith DJ, Mercer SW and Wild SH: Incidence of ischaemic heart disease and stroke among people with psychiatric disorders: Retrospective cohort study. Br J Psychiatry. 217:442–449. 2020.PubMed/NCBI View Article : Google Scholar

6 

Gul-Kahraman K, Yilmaz-Bozoglan M and Sahna E: Physiological and pharmacological effects of melatonin on remote ischemic perconditioning after myocardial ischemia-reperfusion injury in rats: Role of Cybb, Fas, NfκB, irisin signaling pathway. J Pineal Res. 67(e12589)2019.PubMed/NCBI View Article : Google Scholar

7 

Merz SF, Korste S, Bornemann L, Michel L, Stock P, Squire A, Soun C, Engel DR, Detzer J, Lörchner H, et al: Contemporaneous 3D characterization of acute and chronic myocardial I/R injury and response. Nat Commun. 10(2312)2019.PubMed/NCBI View Article : Google Scholar

8 

Stiermaier T, Jensen JO, Rommel KP, de Waha-Thiele S, Fuernau G, Desch S, Thiele H and Eitel I: Combined intrahospital remote ischemic perconditioning and postconditioning improves clinical outcome in ST-elevation myocardial infarction. Circ Res. 124:1482–1491. 2019.PubMed/NCBI View Article : Google Scholar

9 

Tsai YT, Liang CH, Yu JH, Huang KC, Tung CH, Wu JE, Wu YY, Chang CH, Hong TM and Chen YL: A DNA aptamer targeting galectin-1 as a novel immunotherapeutic strategy for lung cancer. Mol Ther Nucleic Acids. 18:991–998. 2019.PubMed/NCBI View Article : Google Scholar

10 

Kuroi K, Kamijo M, Ueki M, Niwa Y, Hiramatsu H and Nakabayashi T: Time-resolved FTIR study on the structural switching of human galectin-1 by light-induced disulfide bond formation. Phys Chem Chem Phys. 22:1137–1144. 2019.PubMed/NCBI View Article : Google Scholar

11 

Huang XT, Liu W, Zhou Y, Sun M, Yang HH, Zhang CY and Tang SY: Galectin-1 ameliorates lipopolysaccharide-induced acute lung injury via AMPK-Nrf2 pathway in mice. Free Radic Biol Med. 146:2222–233. 2020.PubMed/NCBI View Article : Google Scholar

12 

Carlos CP, Silva AA, Gil CD and Oliani SM: Pharmacological treatment with galectin-1 protects against renal ischaemia-reperfusion injury. Sci Rep. 8(9568)2018.PubMed/NCBI View Article : Google Scholar

13 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar

14 

Lameijer H, Schutte JM, Schuitemaker NW, van Roosmalen JJ and Pieper PG: Dutch Maternal Mortality and Morbidity Committee. Maternal mortality due to cardiovascular disease in the Netherlands: A 21-year experience. Neth Heart J. 28:27–36. 2020.PubMed/NCBI View Article : Google Scholar

15 

Seropian IM, González GE, Maller SM, Berrocal DH, Abbate A and Rabinovich GA: Galectin-1 as an emerging mediator of cardiovascular inflammation: Mechanisms and therapeutic opportunities. Mediators Inflamm. 2018(8696543)2018.PubMed/NCBI View Article : Google Scholar

16 

Fan J, Fan W, Lei J, Zhou Y, Xu H, Kapoor I, Zhu G and Wang J: Galectin-1 attenuates cardiomyocyte hypertrophy through splice-variant specific modulation of Ca1.2 calcium channel. Biochim Biophys Acta. 1865:218–229. 2019.PubMed/NCBI View Article : Google Scholar

17 

Seropian IM, Cerliani JP, Toldo S, Van Tassell BW, Ilarregui JM, González GE, Matoso M, Salloum FN, Melchior R, Gelpi RJ, et al: Galectin-1 controls cardiac inflammation and ventricular remodeling during acute myocardial infarction. Am J Pathol. 182:29–40. 2013.PubMed/NCBI View Article : Google Scholar

18 

Han B, Li S, Lv Y, Yang D, Li J, Yang Q, Wu P, Lv Z and Zhang Z: Dietary melatonin attenuates chromium-induced lung injury via activating the Sirt1/Pgc-1α/Nrf2 pathway. Food Funct. 10:5555–5565. 2019.PubMed/NCBI View Article : Google Scholar

19 

Yang Q, Han B, Xue J, Lv Y, Li S, Liu Y, Wu P, Wang X and Zhang Z: Hexavalent chromium induces mitochondrial dynamics disorder in rat liver by inhibiting AMPK/PGC-1α signaling pathway. Environ Pollut. 265(114855)2020.PubMed/NCBI View Article : Google Scholar

20 

Romson JL, Hook BG, Kunkel SL, Abrams GD, Schork MA and Lucchesi BR: Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog. Circulation. 67:1016–1023. 1983.PubMed/NCBI View Article : Google Scholar

21 

Frey UH, Klaassen M, Ochsenfarth C, Murke F, Thielmann M, Kottenberg E, Kleinbongard P, Klenke S, Engler A, Heusch G, et al: Remote ischaemic preconditioning increases serum extracellular vesicle concentrations with altered micro-RNA signature in CABG patients. Acta Anaesthesiol Scand. 63:483–492. 2019.PubMed/NCBI View Article : Google Scholar

22 

Li HL, Karwatowska-Prokopczuk E, Mutomba M, Wu J, Karanewsky D, Valentino K, Engler RL and Gottlieb RA: Pharmacology of caspase inhibitors in rabbit cardiomyocytes subjected to metabolic inhibition and recovery. Antioxid Redox Signal. 3:113–123. 2001.PubMed/NCBI View Article : Google Scholar

23 

Abassi Z, Armaly Z and Heyman SN: Glycocalyx degradation in ischemia-reperfusion injury. Am J Pathol. 190:752–767. 2020.PubMed/NCBI View Article : Google Scholar

24 

Gottlieb RA and Engler RL: Apoptosis in myocardial ischemia-reperfusion. Ann N Y Acad Sci. 874:412–426. 1999.PubMed/NCBI View Article : Google Scholar

25 

Amar DN, Epshtein M and Korin N: Endothelial cell activation in an embolic ischemia-reperfusion injury microfluidic model. Micromachines (Basel). 10(857)2019.PubMed/NCBI View Article : Google Scholar

26 

Gonzalez AL, Ciocci PA, Fantinelli JC, Rojano B, Schinella GR and Mosca SM: Isoespintanol, a monoterpene isolated from oxandra cf xylopioides, ameliorates the myocardial ischemia-reperfusion injury by AKT/PKCepsilon/eNOS-dependent pathways. Naunyn Schmiedebergs Arch Pharmacol. 393:629–638. 2020.PubMed/NCBI View Article : Google Scholar

27 

Elmore S: Apoptosis: A review of programmed cell death. Toxicol Pathol. 35:495–516. 2007.PubMed/NCBI View Article : Google Scholar

28 

Li S, Baiyun R, Lv Z, Li J, Han D, Zhao W, Yu L, Deng N, Liu Z and Zhang Z: Exploring the kidney hazard of exposure to mercuric chloride in mice:Disorder of mitochondrial dynamics induces oxidative stress and results in apoptosis. Chemosphere. 234:822–829. 2019.PubMed/NCBI View Article : Google Scholar

29 

Liu B, Yu H, Baiyun R, Lu J, Li S, Bing Q, Zhang X and Zhang Z: Protective effects of dietary luteolin against mercuric chloride-induced lung injury in mice: Involvement of AKT/Nrf2 and NF-κB pathways. Food Chem Toxicol. 113:296–302. 2018.PubMed/NCBI View Article : Google Scholar

30 

Baiyun R, Li S, Liu B, Lu J, Lv Y, Xu J, Wu J, Li J, Lv Z and Zhang Z: Luteolin-mediated PI3K/AKT/Nrf2 signaling pathway ameliorates inorganic mercury-induced cardiac injury. Ecotoxicol Environ Saf. 161:655–661. 2018.PubMed/NCBI View Article : Google Scholar

31 

Zhu J, Wang YF, Chai XM, Qian K, Zhang LW, Peng P, Chen PM, Cao JF, Qin ZH, Sheng R and Xie H: Exogenous NADPH ameliorates myocardial ischemia-reperfusion injury in rats through activating AMPK/mTOR pathway. Acta Pharmacol Sin. 41:535–545. 2019.PubMed/NCBI View Article : Google Scholar

32 

Xu XZ, Luo B, Xiao Y and Zheng WQ: Effects of lncRNA MALAT1-mediated beta-catenin signaling pathway on myocardial cell apoptosis in rats with myocardial ischemia/reperfusion injury. Eur Rev Med Pharmacol Sci. 23:9557–9565. 2019.PubMed/NCBI View Article : Google Scholar

33 

Lazou A, Iliodromitis EK, Cieslak D, Voskarides K, Mousikos S, Bofilis E and Kremastinos DT: Ischemic but not mechanical preconditioning attenuates ischemia/reperfusion induced myocardial apoptosis in anaesthetized rabbits: The role of Bcl-2 family proteins and ERK1/2. Apoptosis. 11:2195–2204. 2006.PubMed/NCBI View Article : Google Scholar

34 

Wang N, Minatoguchi S, Chen X, Uno Y, Arai M, Lu C, Takemura G, Fujiwara T and Fujiwara H: Antidiabetic drug miglitol inhibits myocardial apoptosis involving decreased hydroxyl radical production and Bax expression in an ischaemia/reperfusion rabbit heart. Br J Pharmacol. 142:983–990. 2004.PubMed/NCBI View Article : Google Scholar

35 

Zhou BZ, Zhang DH, Yu WM and Ning JZ: Protective effect of cyclosporine A in the treatment of severe hydronephrosis in a rabbit renal pelvic perfusion model. Turk J Med Sci. 49:1590–1598. 2019.PubMed/NCBI View Article : Google Scholar

36 

Sheng X, Chen M, Huang B, Liu J, Zhou L, Bao M and Li S: Cardioprotective effects of low-level carotid baroreceptor stimulation against myocardial ischemia-reperfusion injury in canine model. J Interv Card Electrophysiol. 45:131–140. 2016.PubMed/NCBI View Article : Google Scholar

37 

Ho MY, Wen MS, Yeh JK, Hsieh IC, Chen CC, Hsieh MJ, Tsai ML, Yang CH, Wu VC, Hung KC, et al: Excessive irisin increases oxidative stress and apoptosis in murine heart. Biochem Biophys Res Commun. 503:2493–2498. 2018.PubMed/NCBI View Article : Google Scholar

38 

Abhari BA, McCarthy N, Agostinis P and Fulda S: NF-κB contributes to Smac mimetic-conferred protection from tunicamycin-induced apoptosis. Apoptosis. 24:269–277. 2019.PubMed/NCBI View Article : Google Scholar

39 

Toldo S, Mauro AG, Cutter Z and Abbate A: Inflammasome, pyroptosis, and cytokines in myocardial ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol. 315:H1553–H1568. 2018.PubMed/NCBI View Article : Google Scholar

40 

Nichols TC: NF-kappaB and reperfusion injury. Drug News Perspect. 17:99–104. 2004.PubMed/NCBI View Article : Google Scholar

41 

Qian Q, Cao X, Wang B, Qu Y, Qian Q, Sun Z and Feng F: TNF-α-TNFR signal pathway inhibits autophagy and promotes apoptosis of alveolar macrophages in coal worker's pneumoconiosis. J Cell Physiol. 234:5953–5963. 2019.PubMed/NCBI View Article : Google Scholar

42 

Chen H, Zhang RQ, Wei XG, Ren XM and Gao XQ: Mechanism of TLR-4/NF-κB pathway in myocardial ischemia reperfusion injury of mouse. Asian Pac J Trop Med. 9:503–507. 2016.PubMed/NCBI View Article : Google Scholar

43 

Groot HE, Ali LA, van der Horst IC, Schurer RA, van der Werf HW, Lipsic E, van Veldhuisen DJ, Karper JC and van der Harst P: Plasma interleukin 6 levels are associated with cardiac function after ST-elevation myocardial infarction. Clin Res Cardiol. 108:612–621. 2019.PubMed/NCBI View Article : Google Scholar

44 

Moreira DM, da Silva RL, Vieira JL, Fattah T, Lueneberg ME and Gottschall CA: Role of vascular inflammation in coronary artery disease: Potential of anti-inflammatory drugs in the prevention of atherothrombosis. Inflammation and anti-inflammatory drugs in coronary artery disease. Am J Cardiovasc Drugs. 15:1–11. 2015.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Ou D, Ni D, Li R, Jiang X, Chen X and Li H: Galectin‑1 alleviates myocardial ischemia‑reperfusion injury by reducing the inflammation and apoptosis of cardiomyocytes. Exp Ther Med 23: 143, 2022.
APA
Ou, D., Ni, D., Li, R., Jiang, X., Chen, X., & Li, H. (2022). Galectin‑1 alleviates myocardial ischemia‑reperfusion injury by reducing the inflammation and apoptosis of cardiomyocytes. Experimental and Therapeutic Medicine, 23, 143. https://doi.org/10.3892/etm.2021.11066
MLA
Ou, D., Ni, D., Li, R., Jiang, X., Chen, X., Li, H."Galectin‑1 alleviates myocardial ischemia‑reperfusion injury by reducing the inflammation and apoptosis of cardiomyocytes". Experimental and Therapeutic Medicine 23.2 (2022): 143.
Chicago
Ou, D., Ni, D., Li, R., Jiang, X., Chen, X., Li, H."Galectin‑1 alleviates myocardial ischemia‑reperfusion injury by reducing the inflammation and apoptosis of cardiomyocytes". Experimental and Therapeutic Medicine 23, no. 2 (2022): 143. https://doi.org/10.3892/etm.2021.11066
Copy and paste a formatted citation
x
Spandidos Publications style
Ou D, Ni D, Li R, Jiang X, Chen X and Li H: Galectin‑1 alleviates myocardial ischemia‑reperfusion injury by reducing the inflammation and apoptosis of cardiomyocytes. Exp Ther Med 23: 143, 2022.
APA
Ou, D., Ni, D., Li, R., Jiang, X., Chen, X., & Li, H. (2022). Galectin‑1 alleviates myocardial ischemia‑reperfusion injury by reducing the inflammation and apoptosis of cardiomyocytes. Experimental and Therapeutic Medicine, 23, 143. https://doi.org/10.3892/etm.2021.11066
MLA
Ou, D., Ni, D., Li, R., Jiang, X., Chen, X., Li, H."Galectin‑1 alleviates myocardial ischemia‑reperfusion injury by reducing the inflammation and apoptosis of cardiomyocytes". Experimental and Therapeutic Medicine 23.2 (2022): 143.
Chicago
Ou, D., Ni, D., Li, R., Jiang, X., Chen, X., Li, H."Galectin‑1 alleviates myocardial ischemia‑reperfusion injury by reducing the inflammation and apoptosis of cardiomyocytes". Experimental and Therapeutic Medicine 23, no. 2 (2022): 143. https://doi.org/10.3892/etm.2021.11066
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team